Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed the stock exchanges that its officials will attend a group investor meeting arranged by Goldman Sachs on June 17, 2025, from 2:00 PM to 3:30 PM IST in Hyderabad. The meeting will be an in-person group interaction, and the schedule is subject to change due to any last-minute exigencies. The company has clarified that no unpublished price sensitive information (UPSI) will be discussed during the session. The disclosure was made on June 10, 2025, and signed by Company Secretary B. Adi Reddy.
This is a routine investor engagement disclosure with no material information shared, so it is unlikely to have any meaningful impact on the stock price. It simply signals ongoing institutional investor outreach activity.